TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Cash from Financing Activities (2022 - 2023)

Updated

TFA Therapeutics' Cash from Financing Activities came in at $19,171 for Q4 2023, down 33.8% from $28,938 a year earlier.

Analysis

TFA Therapeutics (RAJAF) Cash from Financing Activities (2022 - 2023) Analysis & Trends

For FY2023, TFA Therapeutics' Cash from Financing Activities was $14,643, down 95.3% from FY2022.

  • Cash from Financing Activities has declined in each of the last three years, with a three-year compound annual growth rate of -79.2% (FY2020 to FY2023).
  • Going back by year, Cash from Financing Activities was $309,263 in FY2022 (-46.2%), $574,504 in FY2021 (-64.8%) and $1.63 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Procter & Gamble 387.46 Bn 343.22 Bn 10.28 Bn -6.31 Bn
2 Colgate Palmolive 77.43 Bn 72.16 Bn 3.30 Bn -851.00 Mn
3 Estee Lauder Companies 39.22 Bn 27.30 Bn 2.74 Bn -30.00 Mn
4 Kenvue 37.74 Bn 33.35 Bn 2.30 Bn -587.00 Mn
5 Kimberly Clark 36.82 Bn 34.02 Bn 1.60 Bn 305.00 Mn
6 Church & Dwight 25.66 Bn 24.19 Bn 693.90 Mn -206.80 Mn
7 Clorox 10.68 Bn 8.95 Bn 804.00 Mn 811.00 Mn
8 e.l.f. Beauty 6.74 Bn 5.72 Bn 398.84 Mn -55.46 Mn
9 Reynolds Consumer Products 4.92 Bn 4.59 Bn 245.00 Mn -50.00 Mn
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 48,030.00
Dec 31, 2022 28,938.00
API Access

TFA Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RAJAF&period=max&api_key=YOUR_API_KEY